Evidence map›Paper›PMID 26758906›Full record

Trial reportBMC microbiology2016

Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.

Ranjit Kumar, Craig L Maynard, Peter Eipers, Kelly T Goldsmith, Travis Ptacek, J Aaron Grubbs, Paula Dixon, Donna Howard, David K Crossman, Michael R Crowley and 5 more

Abstract readClinical Trial
In one paragraph

Trial report in BMC microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. The state of play of rodent models for the study ofJournal of medical microbiology · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Lung Microbiome and Its Role in Pneumonia.Clinics in chest medicine · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Duodenal endoluminal barrier sleeve alters gut microbiota of ZDF rats.International journal of obesity (2005) · 2017
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ranjit KumarCenter for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Craig L MaynardDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Peter EipersDepartment of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, 1918 University Blvd. MCLM 680, Birmingham, AL, 35294, USA.
Kelly T GoldsmithDepartment of Genetics and Heflin Center for Genomic Science, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Travis PtacekCenter for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
J Aaron GrubbsDivision of Infectious Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Paula DixonDivision of Infectious Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Donna HowardDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
David K CrossmanDepartment of Genetics and Heflin Center for Genomic Science, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Michael R CrowleyDepartment of Genetics and Heflin Center for Genomic Science, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
William H BenjaminDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Elliot J LefkowitzCenter for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Casey T WeaverDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
J Martin RodriguezDivision of Infectious Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Casey D MorrowDepartment of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, 1918 University Blvd. MCLM 680, Birmingham, AL, 35294, USA. caseym@uab.edu.

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
UAB Center for Clinical and Translational Science (CCTS) UL1UL1TR000165 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2012 to 2013
$9.6M
UAB Skin Diseases Research CenterP30AR050948 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ELMETS, CRAIG A · 2004 to 2013
$5.5M
UAB Infectious Diseases Training GrantT32AI052069 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHWEBKE, JANE R. · 2003 to 2018
$2.1M
NCATS NIH HHS UL1 TR000165NCATS NIH HHS UL1TR000165NCATS NIH HHS UL1 TR001417NCI NIH HHS P30 CA013148NIAID NIH HHS 5P30AI027767NIAID NIH HHS P30 AI027767NIAID NIH HHS T32 AI007051NIAID NIH HHS T32 AI052069NIAMS NIH HHS P30 AR050948NIAMS NIH HHS P30AR050948
6 · The paper itself

Abstract

backgroundFecal microbiota transplants (FMT) are an effective treatment for patients with gut microbe dysbiosis suffering from recurrent C. difficile infections. To further understand how FMT reconstitutes the patient's gut commensal microbiota, we have analyzed the colonization potential of the donor, recipient and recipient post transplant fecal samples using transplantation in gnotobiotic mice.

resultsA total of nine samples from three human donors, recipient's pre and post FMT were transplanted into gnotobiotic mice. Microbiome analysis of three donor fecal samples revealed the presence of a high relative abundance of commensal microbes from the family Bacteriodaceae and Lachnospiraceae that were almost absent in the three recipient pre FMT fecal samples (<0.01%). The microbe composition in gnotobiotic mice transplanted with the donor fecal samples was similar to the human samples. The recipient samples contained Enterobacteriaceae, Lactobacillaceae, Enterococcaceae in relative abundance of 43, 11, 8%, respectively. However, gnotobiotic mice transplanted with the recipient fecal samples had an average relative abundance of unclassified Clostridiales of 55%, approximately 7000 times the abundance in the recipient fecal samples prior to transplant. Microbiome analysis of fecal samples from the three patients early (2-4 weeks) after FMT revealed a microbe composition with the relative abundance of both Bacteriodaceae and Lachnospiraceae that was approximately 7% of that of the donor. In contrast, gnotobioitc mice transplanted with the fecal samples obtained from the three at early times post FMT revealed increases in the relative abundance of Bacteriodaceae and Lachnospiraceae microbe compositions to levels similar to the donor fecal samples. Furthermore, the unclassified Clostridiales in the recipient samples post FMT was reduced to an average of 10%.

conclusionWe have used transplantation into gnotobiotic mice to evaluate the colonization potential of microbiota in FMT patients early after transplant. The commensal microbes present at early times post FMT out competed non-commensal microbes (e.g. such as unclassified Clostridiales) for niche space. The selective advantage of these commensal microbes to occupy niches in the gastrointestinal tract helps to explain the success of FMT to reconstitute the gut microbe community of patients with recurrent C. difficile infections.

Indexed as

Fecal Microbiota TransplantationGastrointestinal MicrobiomeAgedAged, 80 and overAnimalsBacteriaClostridioides difficileClostridium InfectionsFemaleGastrointestinal TractHumansMaleMiceMice, Inbred C57BL

Identifiers

PMID26758906
PMCPMC4711103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.